Mirabegron EP impurity I

Mirabegron EP Impurity I is a piperazine-based derivative characterized by a substituted piperazine ring linked to a branched aliphatic chain containing three nitrogen atoms. The compound lacks the benzyl moiety present in the parent drug, featuring instead a propylamine extension with a terminal methyl group, resulting in a fully aliphatic structure. This impurity arises from an incomplete alkylation step during Mirabegron synthesis, retaining a primary amine functionality at the piperazine nitrogen. The structural simplicity compared to Mirabegron's aromatic substitution pattern renders it a critical marker for monitoring synthetic pathway efficiency. Used as an HPLC reference standard for quantifying process-related impurities in bulk drug substance analysis.